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Recent evidence indicates that arrest of mammalian
cells at the G2/M checkpoint involves inactivation and
translocation of Cdc25C, which is mediated by phospho-
rylation of Cdc25C on serine 216. Data obtained with a
phospho-specific antibody against serine 216 suggest
that activation of the DNA damage checkpoint is accom-
panied by an increase in serine 216 phosphorylated
Cdc25C in the nucleus after exposure of cells to g-radi-
ation. Prior treatment of cells with 2 mM caffeine inhib-
its such a change and markedly reduces radiation-in-
duced ataxia-telangiectasia-mutated (ATM)-dependent
Chk2/Cds1 activation and phosphorylation. Chk2/Cds1
is known to localize in the nucleus and to phosphorylate
Cdc25C at serine 216 in vitro. Caffeine does not inhibit
Chk2/Cds1 activity directly, but rather, blocks the acti-
vation of Chk2/Cds1 by inhibiting ATM kinase activity.
In vitro, ATM phosphorylates Chk2/Cds1 at threonine 68
close to the N terminus, and caffeine inhibits this phos-
phorylation with an IC50 of approximately 200 mM. Using
a phospho-specific antibody against threonine 68, we
demonstrate that radiation-induced, ATM-dependent
phosphorylation of Chk2/Cds1 at this site is caffeine-
sensitive. From these results, we propose a model
wherein caffeine abrogates the G2/M checkpoint by tar-
geting the ATM-Chk2/Cds1 pathway; by inhibiting ATM,
it prevents the serine 216 phosphorylation of Cdc25C in
the nucleus. Inhibition of ATM provides a molecular
explanation for the increased radiosensitivity of caf-
feine-treated cells.
Most effective anti-cancer therapies are genotoxic agents
that damage DNA and kill dividing cells. In addition to apop-
tosis, DNA damage induced by ionizing radiation (IR)1 or other
insults triggers cell cycle checkpoint activation and subsequent
cell cycle arrest, augmenting the ability of cells to repair dam-
aged DNA (1, 2). The checkpoint could contribute to the devel-
opment of drug resistance, a formidable limitation in current
cancer treatment, and consequently agents that override cell
cycle checkpoints could be used to sensitize cells to killing by
genotoxic drugs (3). Proof of this concept has arisen from stud-
ies with caffeine, which causes the disruption of DNA damage
checkpoints (including the G2/M checkpoint), and sensitizes
tumor cells to ionizing radiation and other genotoxic agents (4,
5). However, the mechanism of action of caffeine and its mo-
lecular targets remain unclear. One possible target is phospho-
diesterase, but a more potent phosphodiesterase inhibitor,
3-isobutyl-1-methylxanthine, is unable to abrogate checkpoint
function in many systems (5), suggesting that alternative tar-
gets exist for caffeine.
For mammalian cells, arrest in G2 phase is due largely to
maintenance of inhibitory phosphorylations on Cdc2 (6). De-
phosphorylation of Cdc2 at these sites is catalyzed by the dual
specificity phosphatase Cdc25 (7–9). Recent evidence indicates
that the G2/M DNA checkpoint involves inactivation and pos-
sibly translocation of Cdc25C into the cytoplasm akin to what
has been demonstrated for fission yeast Cdc25 (10–12). This is
at least partially mediated by phosphorylation at serine 216 in
Cdc25C and is likely to involve binding of 14-3-3 proteins to
this phosphorylation site (13, 14). Expression of a Cdc25C
mutant where alanine is substituted for serine 216 (S216A)
induces premature entry into mitosis by overriding a g-radia-
tion-induced DNA damage checkpoint (13). During the normal
progression through the cell cycle, serine 216 phosphorylation
may also contribute to the negative regulation of Cdc25C be-
cause Cdc25C is phosphorylated at this site in interphase but
not during mitosis when Cdc25 is active (13, 15). cTAK1, a
cytoplasmic kinase that phosphorylates Cdc25C specifically at
serine 216 in vitro could be involved in the negative regulation
of Cdc25C in interphase cells (16, 17). On the other hand, the
nuclear kinases Chk1 (13, 15) and Chk2/Cds1 (18–21), which
can phosphorylate Cdc25C at serine 216 in vitro, could contrib-
ute to the maintenance of this phosphorylation in cells arrested
at G2/M in response to DNA damage. So far, only Chk2/Cds1
kinase activity has been shown to increase dramatically in a
checkpoint-dependent manner (18–21). However, it is still un-
clear how DNA damage affects Cdc25C serine 216 phosphoryl-
ation, nor do we know if inhibition of the Chk1 or Chk2/Cds1
pathways alters this phosphorylation. Accumulating data sug-
gest that ataxia-telangiectasia-mutated (ATM) kinase is a
proximal component of DNA damage-induced cell cycle check-
point pathway (22). ATM must play an important role in the
G2/M checkpoint because ATM-deficient cells fail to arrest in
the G2 phase of cell cycle prior to mitosis after DNA damage
(23). It has been demonstrated that radiation-induced Chk2/
Cds1 activation is ATM-dependent (18–21), although it is un-
clear whether activation of Chk1 is also ATM-dependent. It
remains to be shown that ATM directly phosphorylates Chk2/
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Cds1. To study how caffeine abrogates the G2/M checkpoint, it
will be necessary to examine how caffeine affects the known
G2/M checkpoint signal transduction pathway involving the
phosphorylation of serine 216 on Cdc25C.
We present evidence here showing that caffeine inhibits ATM-
dependent activation of Chk2/Cds1 in vivo. In vitro, caffeine did
not inhibit Chk2/Cds1 directly but instead inhibited ATM at an
IC50 of approximately 200 mM. During the preparation of this
manuscript, similar findings that caffeine can inhibit ATM
kinase activity were reported (24, 25). Our study provides
further mechanistic details of how this inhibition can lead to
the abrogation of the G2/M checkpoint. Using a recently gen-
erated phospho-specific antibody against serine 216, we dem-
onstrate that activation of the DNA damage checkpoint is
correlated with an increase in serine 216-phosphorylated
Cdc25C in the nucleus and further, that prior treatment of cells
with caffeine inhibits such a change. In addition, we provide
evidence showing that ATM phosphorylates Chk2/Cds1 at thre-
onine 68 in the N terminus, also in a caffeine-sensitive manner.
Finally, caffeine is shown to inhibit ATM-dependent Chk2/
Cds1 phosphorylation in vivo. Using a phospho-specific anti-
body against threonine 68, we found that Chk2/Cds1 is phos-
phorylated at this site in vivo in cells after IR exposure, and
this phosphorylation is inhibited by prior treatment of cells
with caffeine. These results are consistent with a model in
which caffeine abrogates the G2/M checkpoint by targeting the
ATM-Chk2/Cds1 pathway by inhibiting ATM.
EXPERIMENTAL PROCEDURES
Constructs and Recombinant Proteins—To make a kinase-dead
Chk2, aspartic acid 347 was converted to alanine by site-directed mu-
tagenesis. Full-length wild type and kinase-dead (KD) Chk2 (D347A)
were subcloned into pFASTBAC as GST fusion protein (Invitrogen) for
baculovirus expression. Recombinant Chk2-GST proteins were purified
by a glutathione-Sepharose affinity step followed by a gel filtration
column. Full-length kinase-dead (KD) Chk2 and threonine 68 to alanine
mutant, N terminus (amino acids 1–222), and C terminus of Chk2
(amino acids 206–543, with D347A mutation) were also subcloned into
pGEX-5X for expression in bacteria and subsequently purified as GST
fusion proteins as described above.
Antibodies—Phosphopeptides of the following sequence were synthe-
sized: phospho-S216, GLYRSP-pS-MPENLNR; phospho-T68, SS-
LETVS-pT-QELYS, and coupled to KLH. Phosphospecific antibodies to
the KLH-coupled peptides were obtained and purified. Anti-Chk2 was
described in Chaturvedi et al. (21). Anti-ATM was purchased from
Oncogene Research Products (Cambridge, MA), anti-Cdc25C (C-20)
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and anti-phos-
pho-S15 of p53 from New England Biolabs (Beverly, MA).
Immunostaining—MRC-5 cells were plated in microchamber slides
overnight and irradiated the next day with 20 Gy of IR and then
incubated at 37 °C for 30 min before fixing and staining. Untreated cells
and cells processed with secondary antibody alone were included as
controls. The cells were fixed for 10 min in PBS-buffered paraformal-
dehyde, 2% sucrose solution, followed by permeabilization for 10 min in
cold buffer containing 0.5% Triton X-100 in 20 mM Hepes, pH 7.4, 3 mM
MgCl2, 50 mM NaCl, and 300 mM sucrose (26). They were then blocked
in 3% bovine serum (BSA) in PBS-Tween 20 and incubated in primary
antibody at 1:3000 dilution in PBS-BSA for 1 h at 4 °C before washing
three times with PBS-BSA. The slides were incubated in fluorescein
isothiocyanate-labeled secondary antibody in PBS-BSA for 1 h, washed
three times with PBS-BSA, twice with PBS alone, and then dry-
mounted. The slides were seen under an inverted florescence micro-
scope (OLYMPUS BX-60).
Extract Preparation—Whole cell extracts were prepared as described
(21). Nuclear and cytoplasmic extracts were prepared using a kit from
Pierce. Cells were grown in 100-ml flasks and treated with caffeine (2
mM) overnight and irradiated with 20 Gy. They were then removed by
scraping and collected by centrifugation, and the pellets were lysed in
extraction buffer to obtain the cytoplasmic fractions in the supernatant.
The remaining pellets containing the nuclear fraction were then
washed thoroughly three times with PBS and lysed in extraction buffer
to obtain the nuclear extract.
Kinase Assays—Chk2 kinase assays (21) and ATM kinase assays (27)
were performed as described. ATM was immunoprecipitated by adding
anti-ATM antibody to total cell lysates and incubating with protein
G-Sepharose for 2 h at 4 °C. Kinase assays were performed on the beads
by incubating the resulting complexes in kinase buffer containing 10
mM Hepes (pH 7.5), 50 mM b-glycerophosphate, 50 mM NaCl, 10 mM
MgCl2, 10 mM MnCl2, 1 mM dithiothreitol, 5 mM ATP, 10 mCi of
[32P]ATP, and 1 mg of substrate for 30 min at 30 °C, and products were
analyzed by SDS-PAGE followed by autoradiography.
RESULTS
Caffeine Abrogates the g-Radiation-induced Increase in Ser-
ine 216 Phosphorylation of Cdc25C in the Nucleus—It has been
established that the G2/M DNA checkpoint is at least partially
mediated by phosphorylation of serine 216 in Cdc25C (13, 14).
To study the role of serine 216 in this checkpoint, we raised an
antibody to a phosphopeptide surrounding the serine 216 phos-
phorylation site. To test the specificity of the antibody, we
performed an in vitro assay using GST-Chk2 as the active
kinase and GST-Cdc25C as the substrate. A kinase-dead Chk2
fusion protein (D347A) was included as a negative control. The
assay mixture was resolved on 10% SDS-PAGE and blotted
with anti phospho-S216 antibody. As shown in the Western blot
(Fig. 1A, lane 3), the phospho-S216 antibody recognized
Cdc25C that was incubated with a wild type Chk2 in the in
vitro kinase assay but failed to recognize unphosphorylated
Cdc25C, incubated with a kinase-dead mutant (D347A) (Fig.
1A, lane 2). Moreover, a peptide surrounding serine 216
blocked the antibody recognition (data not shown). These find-
ings indicate that the anti-phospho-S216 antibody recognizes
Cdc25C specifically when it is phosphorylated at serine 216
and confirms that Chk2/Cds1 phosphorylates Cdc25C at serine
216 in vitro.
FIG. 1. Caffeine inhibition of the increase in serine 216 phos-
phorylation of Cdc25C upon g-irradiation. A, wild-type GST-Chk2,
kinase-dead mutant (D347A) (1KD Chk2), or mock control was incu-
bated in the presence of [32P]ATP and 1 mg of GST-Cdc25C fusion
protein. 1% of each reaction mixture was analyzed by immunoblot with
anti-phospho-S216 antibody. B, normal (MRC-5) and A-T (AGO4405)
cells were either mock-treated (2) or treated with 20 Gy of g-radiation
(IR) (1) in the presence (1) or the absence (2) of 2 mM caffeine. Nuclear
and cytoplasmic extracts were made and resolved by 10% SDS-PAGE.
Phosphorylation in serine 216 of Cdc25C was detected by anti-phospho-
S216 antibody.
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To determine the intracellular localization of serine 216-
phosphorylated Cdc25C and the effect of DNA damage check-
point activation on serine 216 phosphorylation, biochemical
fractionation experiments were performed using asynchro-
nously growing MRC-5 cells before and immediately after IR
with or without prior treatment of cells with caffeine. Whole-
cell, cytoplasmic, or nuclear extracts were prepared as de-
scribed under “Experimental Procedures.” Equal amounts of
protein in each sample were resolved on 10% SDS-PAGE,
transferred to membranes, and blotted with anti-phospho-S216
and anti-Cdc25c antibody, respectively. Serine 216-phosphoryl-
ated Cdc25C was detected predominantly in the cytoplasmic
extracts and to a lesser extent in the nuclear fraction (Fig. 1B,
lanes 1 and 5). As a control for biochemical fractionation, nu-
clear protein nucleolin was found to be localized in the nuclear
fractions (data not shown). Immediately after IR, an increase in
serine 216-phosphorylated Cdc25C was observed in the nuclear
fraction (Fig. 1B, lane 2), and prior treatment of cells with
caffeine inhibited this increase (Fig. 1B, lane 4). On the other
hand, there was no appreciable increase in serine 216 phospho-
rylation in whole cell lysates (data not shown), consistent with
the observation that the majority of serine 216-phosphorylated
Cdc25C is in the cytoplasm (Fig. 1B, lane 5). Caffeine alone did
not alter serine 216 phosphorylation in the absence of IR (Fig.
1B, lane 3). Cdc25C was partitioned between nuclear and cy-
toplasmic fractions similarly to serine 216-phosphorylated
Cdc25C. No gross relocation of Cdc25C was observed immedi-
ately after IR (Fig. 1B, lanes 2 and 6). Our data support a model
that an increase in serine 216 phosphorylation in the nucleus is
caused by the activation of serine 216 kinase but cannot totally
rule out the possibility of nuclear relocation of Cdc25C as an
alternative mechanism. This finding implies that caffeine could
inhibit the activation of the serine 216 kinase in the nucleus
after IR at a concentration at which it can abrogate the G2/M
checkpoint.
To confirm the cellular localization of phosphorylated
Cdc25C after IR, indirect immunofluoresence analysis of nor-
mal diploid human fibroblasts (MRC-5) was performed. Ac-
tively proliferating cells were g-irradiated and allowed to re-
cover for 30 min at 37 °C before immunostaining. As a negative
control, cells were left untreated or unirradiated. As shown in
Fig. 2, punctate staining for serine 216 was obtained; in con-
trast to the results of biochemical fractionation experiments
(Fig. 1B), serine 216 staining was found to be enriched in the
nucleus of both irradiated and unirradiated samples. Cytoplas-
mic staining was diminished in all the samples. This can be
explained by the fact that phosphorylated serine 216 epitope is
perhaps not exposed in the cytoplasm due to interaction with
14-3-3 proteins as has been reported previously (13, 14). We
observed a possible increase in nuclear serine 216 reactivity
after IR treatment of cells as these cells stained brighter than
the unirradiated cells (Fig. 2).
To determine whether the increase in serine 216 phospho-
rylation observed after radiation is ATM-dependent, we re-
peated the biochemical fractionation experiment using the A-T
cell line AGO4405. No change in anti-phospho-S216 staining
was observed in AGO4405 cells after IR exposure (Fig. 1C,
lanes 1 and 2), and caffeine had no effect in the A-T cells (Fig.
1C, lanes 3 and 4). These results demonstrate that radiation-
induced phosphorylation of Cdc25C on serine 216 in the nu-
cleus is dependent on ATM and is inhibited by caffeine.
Caffeine Inhibits Chk2/Cds1 Activation in an ATM-depend-
ent Manner—Which serine 216 kinase does caffeine affect in
the nucleus? Both Chk1 and Chk2/Cds1 have been shown to
localize to the nucleus and to phosphorylate serine 216 of
Cdc25C in vitro (13, 15) (18–21). Although the phosphorylation
state of Chk1 is altered in response to DNA damage (15), it does
not correspond to an increase in its kinase activity toward
Cdc25C.2 It is still unclear whether Cdc25C is a substrate for
Chk1 in vivo. On the other hand, Chk2/Cds1 kinase activity
toward Cdc25C increases substantially after IR in an ATM-de-
pendent manner (18–21). To test the possibility that Chk2/
Cds1 is a target for caffeine in abrogating the G2/M checkpoint,
we determined whether ATM-dependent Chk2/Cds1 activation
is inhibited by caffeine. Immunoprecipitate kinase assays were
performed using total lysates prepared from normal (MRC-5)
and A-T (AGO4405) cells treated with caffeine and then irra-
diated with 20 Gy of radiation using GST-Cdc25C as a sub-
strate (21). Lysates from cells that were untreated, treated
with caffeine alone, and g-irradiated alone were included in the
assay as controls. As shown in Fig. 3A in normal cells, IR
causes activation of Chk2/Cds1 (lane 2), and this activation is
inhibited by prior treatment of cells with caffeine (lane 4).
However, no such activation was found in A-T cells indicating
that caffeine inhibited the ATM-dependent Chk2/Cds1 activa-
tion (Fig. 3A, lanes 6 and 8). The Chk2 activity was also
2 K. K. Khanna, S. Kozlov, and B. Gabrielli, unpublished results.
FIG. 2. Cellular localization of phosphorylated serine 216 in
Cdc25C in MRC5 cells. MRC-5 cells were either left untreated (Con-
trol) or treated with 20 Gy of g-radiation. MRC-5 cells after different
treatments were immunostained with anti-phospho-S216 antibody and
visualized by immunofluoresence microscopy
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measured by an immunoassay using anti-phospho-S216 anti-
body (Fig. 3B). Reaction mixtures identical to those used in the
radioactive kinase assay were analyzed on 10% SDS-PAGE,
transferred onto nitrocellulose membrane, and blotted with
anti-phospho-S216. Serine 216 phosphorylation activity of
Chk2 was clearly increased in response to DNA damage (Fig.
3B, lane 2), and the increase was prevented by prior treatment
of cells with caffeine (Fig. 3B, lane 4). Again no effect of caffeine
was found in A-T cells (Fig. 3B, lane 8). To examine whether
Chk2/Cds1 is a direct target of caffeine, an in vitro kinase assay
was performed with recombinant Chk2 using GST-Cdc25C as a
substrate in the presence or absence of increasing concentra-
tions of caffeine. A kinase-dead mutant of Chk2 (D347A) was
included as a negative control in the assay. Caffeine did not
inhibit the kinase activity of Chk2 even at a concentration of 2
mM (Fig. 3C) suggesting that Chk2 is not a direct target; in-
stead, caffeine might inhibit either ATM kinase activity or the
pathway leading to Chk2/Cds1 activation.
ATM Phosphorylates Chk2/Cds1 in Vitro—Chk2/Cds1 acti-
vation after IR has been shown to depend on ATM kinase
activity (18–21). To test the possibility that ATM can phospho-
rylate Chk2/Cds1 directly, active ATM was immunoprecipi-
tated from normal human lymphoblastoid C3ABR cells that
had been either g-irradiated or mock-treated. ATM nonex-
pressing human A-T lymphoblast (L3) cells were used as a
negative control. Because wild type Chk2 has a high level of
autophosphorylation activity (data not shown), kinase-dead
Chk2 mutant (D347A) was used as the substrate in the ATM
kinase assay. As shown in Fig. 4A, ATM immunoprecipitated
from C3ABR phosphorylated Chk2/Cds1 directly, and ATM
activity increased by approximately 4-fold after radiation. In
negative control A-T cells (L3), there is only background phos-
phorylation of Chk2. To analyze the location of phosphoryla-
tion, we expressed Chk2 as two separate domains: the N-
terminal domain, containing amino acids 1–222; and the
C-terminal domain (with D347A mutation to inactivate kinase
activity), containing amino acids 206–543. As shown in Fig. 4A,
most of the phosphorylation was in the N-terminal domain;
there was very little in the C-terminal domain (D347A). Simi-
larly constructed wild type C-terminal domain is kinase-active
(data not shown), indicating that misfolding is not a cause of
the lack of phosphorylation. Analysis of the Chk2/Cds1 se-
quence within this region revealed a cluster of serines (S) and
threonines (T) followed by glutamine (Q) (SQ or TQ). SQ or TQ
sequences are the preferred sites of ATM phosphorylation on
p53 and c-Abl (27–29). Among different SQ and TQ sites in the
N-terminal of Chk2/Cds1, the sequence around threonine 68
(STQE) is the closest to the preferred ATM phosphorylation
sites on p53 (LSQE) and c-Abl (LSQV) (27–29), suggesting
threonine 68 as a possible site for ATM phosphorylation in
Chk2/Cds1. Substitution of threonine 68 by alanine in the
full-length kinase-dead Chk2 dramatically reduced but did not
abolish the ATM phosphorylation of Chk2/Cds1 in vitro (Fig.
4B; threonine 68 accounts for approximately 70% of the total
phosphorylation). To confirm that threonine 68 of Chk2/Cds1 is
the site of ATM phosphorylation in vitro and to study its role in
vivo, we raised antibodies to a phosphopeptide surrounding the
phosphorylation site. To test the specificity of the antibody, we
performed an in vitro assay using immunoprecipitated ATM as
kinase and kinase-dead GST-Chk2 as substrate. As shown in
the Western blot (Fig. 4C), the phospho-T68 antibody recog-
nized Chk2 that was incubated with immunoprecipitated ATM
FIG. 3. Caffeine inhibition of ATM-dependent Chk2/Cds1 acti-
vation. A, MRC-5 cells (Normal) and AGO4405 cells (A-T) were treated
with 20 Gy of g-radiation (IR) (1) or left untreated (2) in the presence
(1) or the absence (2) of 2 mM caffeine. The cell lysates were immuno-
precipitated with anti-Chk2 antibody, and kinase assays were per-
formed using GST-Cdc25C as a substrate. The reaction mixtures were
resolved by SDS-PAGE, and the 32P-labeled GST-Cdc25C were visual-
ized by autoradiography. The relative Chk2 activities are shown graph-
ically. B, the same reaction mixtures as in A were resolved by SDS-
PAGE, and the phosphorylated GST-Cdc25C was detected by serine 216
phospho-specific antibody. C, caffeine did not inhibit Chk2 directly.
Purified recombinant GST-Chk2 (1) or negative control (2 or KD) were
incubated with GST-Cdc25C at increasing amounts of caffeine. The
reaction mixture were resolved by SDS-PAGE, and the 32P-labeled
GST-Cdc25C were visualized by autoradiography. Inactive GST-Chk2
(D347A) (KD) was used as a negative control.
FIG. 4. ATM phosphorylates Chk2 directly in vitro. A, immuno-
precipitated ATM from C3ABR cells (normal) and L3 cells (A-T) before
or after g-radiation (IR) were incubated with purified GST-Chk2
(D347A) (KD), GST-Chk2-N-terminal (amino acids 1–222), and GST-
Chk2-C-terminal (D347A) (amino acids 206–543) in the kinase assay.
B, immunoprecipitated ATM from C3ABR cells before or after g-radia-
tion (IR) were incubated with purified kinase-dead (KD) GST-Chk2
(Control) and threonine 68 to alanine mutant (T68A) in the kinase
assay. C, the same reaction mixtures show in A using GST-Chk2
(D347A) (KD) were probed with anti-phospho-T68 antibody.
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in the kinase assay but failed to recognize unphosphorylated
Chk2. These findings indicate that the anti-phospho-T68 spe-
cifically recognizes Chk2 when it is phosphorylated at threo-
nine 68 and confirm that ATM phosphorylates Chk2 at threo-
nine 68 in vitro.
Caffeine Inhibits ATM-dependent Chk2 Phosphorylation in
Cells and ATM Phosphorylation of Purified Recombinant
Chk2—It is possible that ATM is also an in vivo kinase for
Chk2 and that caffeine inhibits Chk2 activation by inhibiting
ATM kinase activity. To test whether caffeine can inhibit the
ATM-dependent Chk2 phosphorylation in cells, Western blots
were generated using extracts made from both normal cells
(MRC-5) and AT cells (AGO4405) before and after g-irradiation
with or without prior treatment with caffeine. Equal amounts
of protein in each sample were separated by 10% SDS-PAGE,
and the gels were transferred and blotted with anti-Chk2 an-
tibody. Fig. 5A shows that even though the levels of Chk2 in all
samples were comparable, the migration of Chk2 protein from
g-irradiated cells was slower (lane 2) than that in the control
(lane 1); in cells treated with caffeine prior to g-irradiation,
however, the mobility shift was not observed (lane 4). The
change in mobility is attributed to the phosphorylation of Chk2
in an ATM-dependent manner (18–21), and thus prior treat-
ment with caffeine inhibits this ATM-dependent phosphoryla-
tion. Because threonine 68 of Chk2 is the ATM phosphorylation
site in vitro, we utilized anti-phospho-T68 antibody to deter-
mine whether threonine 68 was phosphorylated upon ATM
activation in response to g-radiation, and whether this phos-
phorylation could be inhibited by caffeine. Due to nonspecific
contaminating bands in the cytoplasm recognized by anti-phos-
pho-T68 (data not shown), nuclear extracts of cells treated as in
Fig. 5A were used for immunoblotting. As shown in Fig. 5B,
immediately after g-irradiation, the amount of threonine 68-
phosphorylated Chk2 increased (lane 2), and prior treatment of
cells with caffeine markedly reduced this increase (lane 4).
There is still a slight increase in threonine 68 phosphorylation
in IR and caffeine-treated sample (Fig. 5B, lane 4), which failed
to show a mobility shift (Fig. 5A), implying that other phospho-
rylation sites could be also involved in the shift. These results
support a model in which ATM is the kinase that phosphoryl-
ates Chk2/Cds1 in cells in response to DNA damage, and caf-
feine inhibits the Chk2/Cds1 activation by inhibiting ATM
kinase activity.
To see whether caffeine can inhibit ATM phosphorylation of
Chk2 directly, the ATM kinase reaction was performed in the
presence of various concentrations of caffeine. Active ATM was
immunoprecipitated from normal human lymphoblastoid
C3ABR cells that were either g-irradiated or mock-treated, and
kinase-dead Chk2 mutant (D347A) was used as the substrate
in the ATM kinase assay. As shown in Fig. 6A, ATM immuno-
precipitated from irradiated cells was more active than that
from unirradiated cells, and both the basal and radiation-
induced ATM activities were inhibited by caffeine with an IC50
at around 200 mM. The ATM activity was also measured by an
immunoassay using anti-phospho-T68 antibody (Fig. 6B). The
same reaction mixture as in the radioactive kinase assay was
analyzed on 10% SDS-PAGE, transferred onto nitrocellulose
membrane, and blotted with anti-phospho-T68. As shown in
Fig. 6B, threonine 68 phosphorylation activity of ATM was also
inhibited by caffeine with similar IC50 as that measured by the
radioactive kinase assay. Because caffeine induces radiosensi-
tization and inhibits checkpoint functions at concentrations of
0.5 to 5 mM, the results of the in vitro kinase assay suggest that
ATM is a relevant target for caffeine in intact cells.
Caffeine Inhibits ATM Phosphorylation of p53 Both in Vitro
and in Vivo—Recent studies have suggested that ATM is also
the in vivo kinase phosphorylating p53 on serine 15 at short
times after exposure of cells to g-radiation (27, 29, 30). To
confirm that ATM is a direct target of caffeine, we initially
determined whether caffeine could inhibit ATM phosphoryla-
tion of p53 in vitro. Immunoprecipitated ATM was incubated
with the purified N-terminal fragment of p53 (amino acids
1–40) in the kinase reaction in the presence of increasing
FIG. 5. Caffeine inhibits the ATM-dependent phosphorylation
of Chk2 in vivo. A, MRC-5 cells (Normal) and AGO4405 cells (A-T)
were treated with 20 Gy of g-radiation (IR) (1) or left untreated (2)
with (1) or without (2) prior treatment of 2 mM caffeine. The cells were
lysed on harvesting, and equal amounts of protein in each sample were
resolved by 10% SDS-PAGE and immunoblotted with anti-Chk2 anti-
body. B, nuclear extracts were made from similarly treated cells as
described in A. Equal amounts of protein in each sample were resolved
by 10% SDS-PAGE and immunoblotted with anti-phospho-T68
antibody.
FIG. 6. Caffeine inhibits ATM kinase activity in vitro. A, immu-
noprecipitated ATM from C3ABR cells before or after g-radiation (IR)
were incubated with purified GST-Chk2 (D347A) (KD) in the kinase
assay in the presence of various concentrations of caffeine. Upper panel,
autoradiography; lower panel, relative ATM kinase activity versus caf-
feine concentration. l , 1IR, M, 2IR. B, the same reaction mixtures in
the absence (0 mM caffeine) or the presence of 600 mM caffeine shown in
A were resolved by SDS-PAGE and probed with anti-phospho-T68
antibody.
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concentrations of caffeine. Serine 15 in the N terminus of p53
has been shown to be the preferred ATM phosphorylation site
(27, 29, 30). As shown in Fig. 7A, ATM immunoprecipitated
from irradiated cells was more active than that from control
cells, and both ATM activities were inhibited by caffeine with
IC50 at around 200 mM. To determine whether caffeine inhibits
ATM phosphorylation of p53 on serine 15 in vivo, Western blot
experiments using anti-phosphoserine 15 were performed on
extracts made from C3ABR cells before and after g-irradiation
with or without prior treatment with caffeine. As shown in Fig.
7B, there is a dramatic increase in serine 15 phosphorylated
p53 after radiation (Lane 2), which is markedly reduced by
prior treatment with caffeine (Lane 4). These results suggested
that ATM phosphorylation of p53 can be inhibited by caffeine,
consistent with the hypothesis that ATM is the molecular tar-
get of caffeine.
DISCUSSION
Although caffeine has been a useful tool in discerning the
existence of DNA damage checkpoints, the underlying mecha-
nism is not clear. The ability of caffeine to block radiation-
induced G2 arrest suggests that it targets one of the proteins
involved in the activation of the G2/M checkpoint. In this com-
munication, we provide evidence that the ability of caffeine to
abrogate the checkpoint is correlated with its ability to inhibit
the radiation-induced increase in Cdc25C serine 216 phospho-
rylation in the nucleus, probably through inhibiting the ATM-
Chk2/Cds1 pathway. On the basis of the profound radiation
sensitivity of ATM-deficient cells, these results suggest that
inhibition of ATM by caffeine is responsible for the radiosensi-
tizing effects of this compound.
Although the G2/M DNA checkpoint is believed to be at least
partially mediated by phosphorylation of serine 216 in Cdc25C
(13, 14), the detailed mechanism remains unclear, and it has
been difficult to detect an effect of DNA damage such as that
produced by ionizing radiation on serine 216 phosphorylation.
To overcome these technical difficulties, we raised an antibody
to a phosphopeptide surrounding the serine 216 phosphoryla-
tion site in Cdc25C and found it to be phospho-specific. Using
anti-phospho-S216 antibody, caffeine-sensitive increases in
serine 216-phosphorylated Cdc25C were observed in the nu-
clear fraction immediately after IR. Indirect immunofluores-
ence analysis confirmed this finding. The observed increase in
serine 216 phosphorylation could be a transient event. It will be
of interest to explore this result further, e.g. by studying the
kinetics of the IR-induced increase in serine 216-phosphoryl-
ated Cdc25C in the nucleus and seeing whether translocation
of Cdc25C from the nucleus to cytoplasm follows such phospho-
rylation. Because no obvious relocation of Cdc25C into the
nucleus was observed immediately after irradiation, our re-
sults are consistent with a hypothesis that one or more nuclear
serine 216 kinases is activated after DNA damage (13, 15)
(18–21), and caffeine targets the pathway that leads to kinase
activation.
In response to DNA damage and DNA replication block,
Chk1 and Chk2/Cds1 have been implicated in phosphorylation
of Cdc25C at serine 216 to prevent entry into mitosis (13, 15,
18–21). It is still not clear whether both Chk1 and Chk2/Cds1
kinases are required to prevent mitosis by inhibiting Cdc25C or
whether in the absence of one the other is sufficient for this
function. Although both Chk1 and Chk2/Cds1 are phosphoryl-
ated in response to radiation, only the kinase activity of Chk2/
Cds1 has been shown to increase after DNA damage (18–21).
From the immunoprecipitate kinase studies (Fig. 3), it is evi-
dent that caffeine can inhibit ATM-dependent Chk2/Cds1 acti-
vation because there was a significant reduction in the kinase
activity phosphorylating Cdc25C at serine 216 in normal cells
FIG. 8. Schematic diagram showing how caffeine overrides
DNA-damage G2/M checkpoint by inhibiting ATM.
FIG. 7. Caffeine inhibits the ATM phosphorylation of p53. A,
immunoprecipitated ATM from C3ABR cells before or after g-radiation
(IR) were incubated with purified GST-p53-(1–40) in the kinase assay
in the presence of various concentrations of caffeine. Upper panel,
autoradiography; lower panel, relative ATM kinase activity versus caf-
feine concentration. l , 1IR, M, 2IR. B, C3ABR cells were treated with
20 Gy of g-radiation (IR) (1) or left untreated (2) in the presence (1) or
the absence (2) of 2 mM caffeine. Cell lysates were made and resolved
by 10% SDS-PAGE. Phosphorylation in serine 15 of p53 was detected by
anti-phospho-S15 antibody.
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(ATM1) treated with caffeine. This reduction in phosphoryla-
tion and activation was not found in AT cells, thus indicating
that the ATM-Chk2/Cds1 pathway is one likely target of caf-
feine in abrogating the G2/M checkpoint. Nevertheless, our
results do not exclude the possibility that the Chk1 pathway is
also sensitive to the effects of caffeine on the DNA damage
checkpoint.
ATM-dependent Chk2/Cds1 activation has been suggested to
be correlated with the ATM-dependent phosphorylation of
Chk2/Cds1 (18–21). The experiments reported here show that
ATM phosphorylates Chk2/Cds1 directly in the N-terminal
region in vitro, and threonine 68 is one major phosphorylation
site (Fig. 5). At this point, we do not have evidence that ATM
phosphorylation of Chk2/Cds1 is sufficient for its activation. In
vivo, threonine 68 can be phosphorylated in response to IR in
an ATM-dependent manner. These results suggest that ATM is
a direct kinase for Chk2/Cds1. In vitro, caffeine can inhibit
Chk2 phosphorylation by ATM at an IC50 of 200 mM. Our in vivo
studies (Fig. 6) also show that caffeine can inhibit phosphoryl-
ation of p53, known to be an important substrate of ATM (27,
29, 30). Furthermore, in various assays including serine 216
phosphorylation, Chk2/Cds1 phosphorylation, and activation,
caffeine-treated cells behave the same as A-T cells. These re-
sults support a model (Fig. 8) in which caffeine prevents the
activation of Chk2/Cds1 by inhibiting ATM, which in turn
prevents the serine 216 phosphorylation and inactivation of
Cdc25C in the nucleus, likely through 14-3-3-mediated trans-
location (13, 14). The observation that ATM is the molecular
target of caffeine strengthens the hypothesis that inhibiting
ATM or Chk2/Cds1 will sensitize repair-proficient cancer cells
to radiation therapy and chemotherapy. Recent observations
that p53-deficient cells are preferentially sensitized to radia-
tion-induced killing by caffeine (31–33) suggest that targeting
the ATM pathway might even introduce selectivity to current
cancer therapy. The development of potent and selective inhib-
itors for ATM will provide the means to test this hypothesis.
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